Bilcare Limited
BI.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.28B
Close$
$-90.09
194.8% downside
Current Fair Value
194.8% downsideOvervalued by 194.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.28 Billion |
|---|---|
| Enterprise Value | $2.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.73 |
| Beta | 0.48 |
| Outstanding Shares | 23,545,231 |
Return
| Return on Equity | 10.47% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 29.48 |
|---|---|
| PEG | -6.69 |
| Price to Sales | 0.29 |
| Price to Book Ratio | 3.07 |
| Enterprise Value to Revenue | 0.3 |
| Enterprise Value to EBIT | 4.22 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bilcare Limited
54 employees
CEO: Mohan Harakchand Bhandari Bilcare Ltd. operates as a holding company, primarily focused on offering specialized research solutions for pharmaceutical packaging. Its comprehensive range of services extends to include pharmaceutical packaging, global clinical suppo...